Dr. Tarec Khaled Elajami, MD

Dr. Elajami practices at Mount Sinai Aventura Emergency in Miami, Florida.

Dr. Elajami's NPI, 1174066005, was assigned on November 26, 2016. Dr. Elajami graduated from Beirut Arab University Faculty of Medicine in 2011. Dr. Elajami holds Florida license ME162161.

Dr. Elajami's primary practice is Mount Sinai Aventura Emergency, at 2845 Aventura Blvd, Miami, FL 33180 in Miami-Dade County. The practice phone is (305) 674-2121.

Dr. Elajami's primary practice is Mount Sinai Aventura Emergency in Miami, Florida. Dr. Elajami is also affiliated with Mount Sinai Medical Center. The medical group on file is Mount Sinai Medical Center. Dmand AI also links Dr. Elajami to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Elajami practices, 3 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Elajami's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Elajami is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Elajami's licenses on file in 2 states: Florida and Iowa.

CMS data shows 678 Medicare services from Dr. Elajami across 17 procedure codes in 2024, for 325 Medicare patients. Medicare paid $57,081 for them.

CMS counts 325 Medicare patients who saw Dr. Elajami in 2024. The largest group is 75 to 84, with 118 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 2.12, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Elajami's median patient age at 67, with 44% women.

In 2024, Dr. Elajami wrote 1,123 Medicare Part D claims for 273 patients. 87% of them were for generic drugs. CMS names the drug for 941 of them, across 22 drugs with 11 or more claims each, at $111,208 in total drug cost. In 2023, CMS named 1,540 claims across 26 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Elajami for performance year 2024, reported as part of a group. Dr. Elajami accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Elajami as offering telehealth.

Dmand AI links 31 papers to Dr. Elajami, published from 2014 to 2025. 2025 was the busiest year, with 6. The most frequent topics are Coronary Artery Disease, Docosahexaenoic Acids and Eicosapentaenoic Acid. Dr. Elajami has published most often in J Am Heart Assoc. Dr. Elajami's most frequent co-authors are Christos George Mihos, DO, Esteban Escolar, MD and Mohamad Iqbal Saleh, MD.

CMS Open Payments shows 175 general payments to Dr. Elajami from 34 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. Boston Scientific Corporation paid the most, $893.

Dr. Elajami graduated from Beirut Arab University Faculty of Medicine in 2011.

Dr. Elajami is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.